Three Indian Generics Win U.S. FDA Approval For Breast Cancer Drug
This article was originally published in PharmAsia News
Executive SummaryThree Indian drug makers, acting separately, have launched generic versions of a breast cancer drug on the U.S. market
You may also be interested in...
The HMA-EMA Big Data Task Force has offered recommendations to use data for the benefit of public health.